Relates to directing the New York state health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of Lyme disease.
STATE OF NEW YORK
________________________________________________________________________
6927
2017-2018 Regular Sessions
IN ASSEMBLY
March 24, 2017
___________
Introduced by M. of A. HUNTER -- read once and referred to the Committee
on Insurance
AN ACT to amend the insurance law, in relation to directing the New York
state health care quality and cost containment commission to study and
report upon the impact of requiring that certain health insurance
plans provide coverage for treatment of lyme disease
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Section 213 of the insurance law is amended by adding a new
2 subsection (e) to read as follows:
3 (e) The commission shall cause a study to be performed on the impact
4 of requiring certain health insurance plans to provide coverage for
5 treatment of lyme disease. Such study shall include an assessment of the
6 impact of such a requirement on costs to providers, the cost of insur-
7 ance premiums, and the fiscal impact to the state. The commission shall
8 submit a report of the findings, conclusions and recommendation of such
9 study, on or before November thirtieth, two thousand eighteen, to the
10 governor, the temporary president of the senate, the speaker of the
11 assembly, the chairs of the senate and assembly insurance committees,
12 and the chairs of the senate and assembly health committees.
13 § 2. This act shall take effect immediately.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD10729-01-7
